Evaluation of long-term results of homograft and heterograft valves in extracardiac conduits. 1987

C Bull, and F J Macartney, and P Horvath, and R Almeida, and W Merrill, and J Douglas, and J F Taylor, and M R de Leval, and J Stark

Between 1971 and 1982, 249 patients received right heart extracardiac conduits. The 173 patients who survived 30 days were reviewed retrospectively; 72 had antibiotic-sterilized aortic homografts, 97 had xenografts of various types, and four had valveless tubes. Reoperation for conduit obstruction was required as early as 13 months after the original operation, but actuarial analysis showed no differences in overall performance of homograft and heterograft conduit groups with respect to late death or survival free of conduit obstruction. More important risk factors for late death or the need for reoperation were the severity of the underlying cardiac lesions and the influence of early postoperative complications. When analyzed statistically, the performance of conduits bearing homografts was disappointing, influenced sometimes by complications in the Dacron extension tubes. Repairs dispensing with conduits entirely should be evaluated.

UI MeSH Term Description Entries
D012086 Reoperation A repeat operation for the same condition in the same patient due to disease progression or recurrence, or as followup to failed previous surgery. Revision, Joint,Revision, Surgical,Surgery, Repeat,Surgical Revision,Repeat Surgery,Revision Surgery,Joint Revision,Revision Surgeries,Surgery, Revision
D001807 Blood Vessel Prosthesis Device constructed of either synthetic or biological material that is used for the repair of injured or diseased blood vessels. Vascular Prosthesis,Blood Vessel Prostheses,Tissue-Engineered Vascular Graft,Graft, Tissue-Engineered Vascular,Grafts, Tissue-Engineered Vascular,Prostheses, Blood Vessel,Prostheses, Vascular,Prosthesis, Blood Vessel,Prosthesis, Vascular,Tissue Engineered Vascular Graft,Tissue-Engineered Vascular Grafts,Vascular Graft, Tissue-Engineered,Vascular Grafts, Tissue-Engineered,Vascular Prostheses,Vessel Prostheses, Blood,Vessel Prosthesis, Blood
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006350 Heart Valve Prosthesis A device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material. Prosthesis, Heart Valve,Cardiac Valve Prosthesis,Cardiac Valve Prostheses,Heart Valve Prostheses,Prostheses, Cardiac Valve,Prostheses, Heart Valve,Prosthesis, Cardiac Valve,Valve Prostheses, Cardiac,Valve Prostheses, Heart,Valve Prosthesis, Cardiac,Valve Prosthesis, Heart
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000206 Actuarial Analysis The application of probability and statistical methods to calculate the risk of occurrence of any event, such as onset of illness, recurrent disease, hospitalization, disability, or death. It may include calculation of the anticipated money costs of such events and of the premiums necessary to provide for payment of such costs. Analysis, Actuarial,Actuarial Analyses,Analyses, Actuarial
D001705 Bioprosthesis Prosthesis, usually heart valve, composed of biological material and whose durability depends upon the stability of the material after pretreatment, rather than regeneration by host cell ingrowth. Durability is achieved 1, mechanically by the interposition of a cloth, usually polytetrafluoroethylene, between the host and the graft, and 2, chemically by stabilization of the tissue by intermolecular linking, usually with glutaraldehyde, after removal of antigenic components, or the use of reconstituted and restructured biopolymers. Glutaraldehyde-Stabilized Grafts,Heterograft Bioprosthesis,Porcine Xenograft Bioprosthesis,Xenograft Bioprosthesis,Bioprostheses,Bioprostheses, Heterograft,Bioprostheses, Porcine Xenograft,Bioprostheses, Xenograft,Bioprosthesis, Heterograft,Bioprosthesis, Porcine Xenograft,Bioprosthesis, Xenograft,Glutaraldehyde Stabilized Grafts,Glutaraldehyde-Stabilized Graft,Graft, Glutaraldehyde-Stabilized,Grafts, Glutaraldehyde-Stabilized,Heterograft Bioprostheses,Porcine Xenograft Bioprostheses,Xenograft Bioprostheses,Xenograft Bioprostheses, Porcine,Xenograft Bioprosthesis, Porcine
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D012306 Risk The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome. Relative Risk,Relative Risks,Risk, Relative,Risks,Risks, Relative

Related Publications

C Bull, and F J Macartney, and P Horvath, and R Almeida, and W Merrill, and J Douglas, and J F Taylor, and M R de Leval, and J Stark
January 1989, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,
C Bull, and F J Macartney, and P Horvath, and R Almeida, and W Merrill, and J Douglas, and J F Taylor, and M R de Leval, and J Stark
February 1984, The Thoracic and cardiovascular surgeon,
C Bull, and F J Macartney, and P Horvath, and R Almeida, and W Merrill, and J Douglas, and J F Taylor, and M R de Leval, and J Stark
June 1989, Current problems in surgery,
C Bull, and F J Macartney, and P Horvath, and R Almeida, and W Merrill, and J Douglas, and J F Taylor, and M R de Leval, and J Stark
December 1988, Journal of cardiac surgery,
C Bull, and F J Macartney, and P Horvath, and R Almeida, and W Merrill, and J Douglas, and J F Taylor, and M R de Leval, and J Stark
August 1987, American heart journal,
C Bull, and F J Macartney, and P Horvath, and R Almeida, and W Merrill, and J Douglas, and J F Taylor, and M R de Leval, and J Stark
February 1980, Artificial organs,
C Bull, and F J Macartney, and P Horvath, and R Almeida, and W Merrill, and J Douglas, and J F Taylor, and M R de Leval, and J Stark
March 1971, The Journal of surgical research,
C Bull, and F J Macartney, and P Horvath, and R Almeida, and W Merrill, and J Douglas, and J F Taylor, and M R de Leval, and J Stark
June 1989, Acta medica Okayama,
C Bull, and F J Macartney, and P Horvath, and R Almeida, and W Merrill, and J Douglas, and J F Taylor, and M R de Leval, and J Stark
March 1975, The Journal of pathology,
C Bull, and F J Macartney, and P Horvath, and R Almeida, and W Merrill, and J Douglas, and J F Taylor, and M R de Leval, and J Stark
March 1995, Nihon Geka Gakkai zasshi,
Copied contents to your clipboard!